Colon and Rectal Surgery

Medicine & Life Sciences

1. Rectal Neoplasms 100%
2. Colectomy 95%
3. Restorative Proctocolectomy 91%
4. Colonic Neoplasms 65%
5. Colorectal Surgery 62%
6. Crohn Disease 60%
7. Colorectal Neoplasms 55%
8. Neoplasms 53%
9. Colon 51%
10. Surgeons 43%
11. Survival 38%
12. Laparoscopy 36%
13. Recurrence 34%
14. Length of Stay 30%
15. Postoperative Complications 30%
16. Robotics 30%
17. vedolizumab 27%
18. Morbidity 26%
19. Inflammatory Bowel Diseases 24%
20. Microbiota 22%
21. Therapeutics 21%
22. Radiotherapy 21%
23. Minimally Invasive Surgical Procedures 20%
24. Proctectomy 20%
25. Bispecific Antibodies 20%
26. Colonic Pouches 20%
27. Ileostomy 20%
28. Ileus 18%
29. Surgical Wound Infection 18%
30. Quality of Life 17%
31. Diverticulitis 17%
32. Databases 17%
33. Fistula 17%
34. Biological Therapy 16%
35. Neoplasm Metastasis 15%
36. Safety 14%
37. Adenocarcinoma 13%
38. Disease-Free Survival 13%
39. Mortality 13%
40. Operative Time 13%
41. Neoadjuvant Therapy 13%
42. Colitis 12%
43. Hand-Assisted Laparoscopy 12%
44. Colonoscopy 11%
45. Rectum 11%
46. Pouchitis 11%
47. Clinical Trials 11%
48. Wounds and Injuries 11%
49. Pelvic Exenteration 11%
50. Systematic Reviews 11%
51. Adenomatous Polyposis Coli 10%
52. Anastomotic Leak 10%
53. Drug Therapy 10%
54. Cohort Studies 10%
55. Mesenchymal Stem Cells 10%
56. Patient Readmission 10%
57. Gastrointestinal Microbiome 9%
58. Polyps 9%
59. Abscess 9%
60. Body Mass Index 9%
61. Electrons 9%
62. Sclerosing Cholangitis 9%
63. Radiation 9%
64. Anal Canal 8%
65. Odds Ratio 8%
66. staphylococcal enterotoxin B 8%
67. Interstitial Cells of Cajal 8%
68. Workflow 8%
69. Lymph Nodes 8%
70. Sepsis 8%
71. Electronic Health Records 8%
72. Quality Improvement 8%
73. Randomized Controlled Trials 8%
74. Demography 7%
75. Adjuvant Chemotherapy 7%
76. Ustekinumab 7%
77. Confidence Intervals 7%
78. Margins of Excision 7%
79. Enhanced Recovery After Surgery 7%
80. Squamous Cell Carcinoma 7%
81. Chemoradiotherapy 7%
82. Credentialing 7%
83. Reoperation 7%
84. Infliximab 7%
85. Operating Rooms 7%
86. Pathologic Constriction 7%
87. Tertiary Care Centers 6%
88. Sigmoid Colon 6%
89. Datasets 6%
90. T-Lymphocytes 6%
91. Carcinoma 6%
92. Obesity 6%
93. Elderly 6%
94. Learning 6%
95. Incidence 6%
96. Costs and Cost Analysis 6%
97. Hand 6%
98. Guidelines 6%
99. Survival Rate 6%